1. Home
  2. INCR vs DMA Comparison

INCR vs DMA Comparison

Compare INCR & DMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INCR
  • DMA
  • Stock Information
  • Founded
  • INCR 1994
  • DMA 2011
  • Country
  • INCR Israel
  • DMA United States
  • Employees
  • INCR N/A
  • DMA N/A
  • Industry
  • INCR Biotechnology: Pharmaceutical Preparations
  • DMA Trusts Except Educational Religious and Charitable
  • Sector
  • INCR Health Care
  • DMA Finance
  • Exchange
  • INCR Nasdaq
  • DMA Nasdaq
  • Market Cap
  • INCR 83.5M
  • DMA 78.0M
  • IPO Year
  • INCR N/A
  • DMA N/A
  • Fundamental
  • Price
  • INCR $1.53
  • DMA $8.85
  • Analyst Decision
  • INCR
  • DMA
  • Analyst Count
  • INCR 0
  • DMA 0
  • Target Price
  • INCR N/A
  • DMA N/A
  • AVG Volume (30 Days)
  • INCR 14.7K
  • DMA 34.6K
  • Earning Date
  • INCR 08-28-2025
  • DMA 01-01-0001
  • Dividend Yield
  • INCR N/A
  • DMA 2.04%
  • EPS Growth
  • INCR N/A
  • DMA N/A
  • EPS
  • INCR N/A
  • DMA N/A
  • Revenue
  • INCR $65,575,323.00
  • DMA N/A
  • Revenue This Year
  • INCR $69.54
  • DMA N/A
  • Revenue Next Year
  • INCR $41.75
  • DMA N/A
  • P/E Ratio
  • INCR N/A
  • DMA N/A
  • Revenue Growth
  • INCR N/A
  • DMA N/A
  • 52 Week Low
  • INCR $1.17
  • DMA $4.78
  • 52 Week High
  • INCR $2.01
  • DMA $8.00
  • Technical
  • Relative Strength Index (RSI)
  • INCR 43.41
  • DMA 68.36
  • Support Level
  • INCR $1.50
  • DMA $8.73
  • Resistance Level
  • INCR $1.59
  • DMA $8.83
  • Average True Range (ATR)
  • INCR 0.05
  • DMA 0.07
  • MACD
  • INCR -0.01
  • DMA 0.02
  • Stochastic Oscillator
  • INCR 20.00
  • DMA 100.00

About INCR Intercure Ltd.

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.

About DMA Destra Multi-Alternative Fund

Destra Multi-Alternative Fund is a non-diversified, closed-end management investment company that operates as an interval fund with a continuous offering of fund shares. The investment objective of the fund is to seek returns from capital appreciation and income with an emphasis on income generation.

Share on Social Networks: